Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECLIPSE: Etokimab in Chronic Rhinosinusitis with Nasal Polyposis
NCT03614923Phase 2Completed
- Sponsor
- AnaptysBio, Inc.
- Start
- Nov 2018
- Primary completion
- Sep 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of etokimab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by AnaptysBio, Inc.. Started Nov 2018; status: completed.
02
Drugs
etokimab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT03614923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03614923.